XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents And Marketable Securities

4. Cash Equivalents and Marketable Securities

Cash equivalents and marketable securities consisted of the following as of June 30, 2022 and December 31, 2021 (in thousands):

 

 

 

Fair Value Measurements at
June 30, 2022

 

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

40,153

 

 

$

 

 

$

 

 

$

40,153

 

Total cash equivalents

 

 

40,153

 

 

 

 

 

 

 

 

 

40,153

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

 

1,998

 

 

 

 

 

 

(3

)

 

 

1,995

 

Commercial paper

 

 

80,192

 

 

 

 

 

 

(895

)

 

 

79,297

 

U.S. Treasury securities

 

 

47,698

 

 

 

 

 

 

(170

)

 

 

47,528

 

Total marketable securities

 

 

129,888

 

 

 

 

 

 

(1,068

)

 

 

128,820

 

Total cash equivalents and marketable securities

 

$

170,041

 

 

$

 

 

$

(1,068

)

 

$

168,973

 

 

 

 

Fair Value Measurements at
December 31, 2021

 

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

 

Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

35,412

 

 

$

 

 

$

 

 

$

35,412

 

Total cash equivalents

 

 

35,412

 

 

 

 

 

 

 

 

 

35,412

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

 

101,697

 

 

 

 

 

 

(329

)

 

 

101,368

 

Commercial paper

 

 

81,450

 

 

 

 

 

 

(68

)

 

 

81,382

 

Total marketable securities

 

 

183,147

 

 

 

 

 

 

(397

)

 

 

182,750

 

Total cash equivalents and marketable securities

 

$

218,559

 

 

$

 

 

$

(397

)

 

$

218,162

 

 

There were no sales of marketable securities during the three and six months ended June 30, 2022. As of June 30, 2022, the aggregate fair value of securities that were in an unrealized loss position for less than twelve months was $128.9 million. As of June 30, 2022, no securities were in an unrealized loss position for greater than twelve months.

The Company determined that it did not hold any securities with any other-than-temporary impairment as of June 30, 2022. As of June 30, 2022, there were no securities with a remaining contractual maturity of greater than one year. As of June 30, 2022, the Company did not intend to sell, and would not be more likely than not be required to sell, the securities in an unrealized loss position